188 related articles for article (PubMed ID: 8576909)
1. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections.
Brickner SJ; Hutchinson DK; Barbachyn MR; Manninen PR; Ulanowicz DA; Garmon SA; Grega KC; Hendges SK; Toops DS; Ford CW; Zurenko GE
J Med Chem; 1996 Feb; 39(3):673-9. PubMed ID: 8576909
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity.
Barbachyn MR; Hutchinson DK; Brickner SJ; Cynamon MH; Kilburn JO; Klemens SP; Glickman SE; Grega KC; Hendges SK; Toops DS; Ford CW; Zurenko GE
J Med Chem; 1996 Feb; 39(3):680-5. PubMed ID: 8576910
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid.
D'Andrea S; Zheng ZB; Denbleyker K; Fung-Tomc JC; Yang H; Clark J; Taylor D; Bronson J
Bioorg Med Chem Lett; 2005 Jun; 15(11):2834-9. PubMed ID: 15911264
[TBL] [Abstract][Full Text] [Related]
5. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
Chien JW; Kucia ML; Salata RA
Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in the discovery of novel oxazolidinone antibacterials.
Gravestock MB
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):469-77. PubMed ID: 16022183
[TBL] [Abstract][Full Text] [Related]
7. [A new antibacterial agent can stop resistance development. Expectations are connected to linezolid, an oxazolidinone with a new pharmacological action].
Sköld O
Lakartidningen; 1999 Sep; 96(37):3866-7. PubMed ID: 10522087
[No Abstract] [Full Text] [Related]
8. Oxazolidinones--a new class of broad-spectrum chemotherapeutics.
Sztanke K; Pasternak K; Sztanke M
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):335-41. PubMed ID: 16146103
[TBL] [Abstract][Full Text] [Related]
9. Oxazolidinones: activity, mode of action, and mechanism of resistance.
Bozdogan B; Appelbaum PC
Int J Antimicrob Agents; 2004 Feb; 23(2):113-9. PubMed ID: 15013035
[TBL] [Abstract][Full Text] [Related]
10. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
Lohray BB; Lohray VB; Srivastava BK; Kapadnis PB; Pandya P
Bioorg Med Chem; 2004 Sep; 12(17):4557-64. PubMed ID: 15358283
[TBL] [Abstract][Full Text] [Related]
11. Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring.
Tucker JA; Allwine DA; Grega KC; Barbachyn MR; Klock JL; Adamski JL; Brickner SJ; Hutchinson DK; Ford CW; Zurenko GE; Conradi RA; Burton PS; Jensen RM
J Med Chem; 1998 Sep; 41(19):3727-35. PubMed ID: 9733498
[TBL] [Abstract][Full Text] [Related]
12. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
Jankowski A; Stefanik W
Wiad Lek; 2006; 59(9-10):727-31. PubMed ID: 17338140
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents.
Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
Zurenko GE; Yagi BH; Schaadt RD; Allison JW; Kilburn JO; Glickman SE; Hutchinson DK; Barbachyn MR; Brickner SJ
Antimicrob Agents Chemother; 1996 Apr; 40(4):839-45. PubMed ID: 8849237
[TBL] [Abstract][Full Text] [Related]
15. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.
Dresser LD; Rybak MJ
Pharmacotherapy; 1998; 18(3):456-62. PubMed ID: 9620097
[TBL] [Abstract][Full Text] [Related]
16. [Linezolid: antibacterial activity, clinical efficacy and resistance].
Bourgeois-Nicolaos N; Piriou O; Butel MJ; Doucet-Populaire F
Ann Biol Clin (Paris); 2006; 64(6):549-64. PubMed ID: 17162258
[TBL] [Abstract][Full Text] [Related]
17. [Linezolid, an agent from a new class of antibiotics].
Kuijper EJ; Schippers EF; Bernards AT
Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
[TBL] [Abstract][Full Text] [Related]
18. Linezolid in vitro: mechanism and antibacterial spectrum.
Livermore DM
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii9-16. PubMed ID: 12730138
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and SAR of novel oxazolidinones: discovery of ranbezolid.
Das B; Rudra S; Yadav A; Ray A; Rao AV; Srinivas AS; Soni A; Saini S; Shukla S; Pandya M; Bhateja P; Malhotra S; Mathur T; Arora SK; Rattan A; Mehta A
Bioorg Med Chem Lett; 2005 Oct; 15(19):4261-7. PubMed ID: 16054358
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antibacterial activities of eperezolid analogs with glycinyl substitutions.
Wang XJ; Wu N; Du GJ; Zhao SQ; Yan M; Gu LQ
Arch Pharm (Weinheim); 2009 Jul; 342(7):377-85. PubMed ID: 19544480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
